Guinea-Bissau cancels trial of hepatitis B vaccine given at birth
By the AFREEQUE newsroom, based on Kassataya

The clinical trial on the non-specific effects of the hepatitis B vaccine administered at birth in Guinea-Bissau has been cancelled, Danish epidemiologist Frederik Schaltz-Buchholzer announced. The study, partly funded by the United States and deemed unethical, will not go ahead, according to his message posted on LinkedIn and reported by Le Monde.
Summary produced with the help of artificial intelligence tools, under AFREEQUE’s editorial responsibility.




